Jay Tal Rubinstein

Jay Rubinstein practices at UW Medical Center - Montlake in Seattle, Washington, part of University of Washington.

Jay Rubinstein's NPI, 1790860518, was assigned on October 27, 2006. Jay Rubinstein graduated from University of Washington School of Medicine in 1988. Jay Rubinstein holds Washington license MD00044088.

Jay Rubinstein's primary practice is UW Medical Center - Montlake, at 1959 NE Pacific St Box 356151, Seattle, WA 98195 in King County. The practice phone is (206) 598-3300.

Jay Rubinstein's primary practice is UW Medical Center - Montlake in Seattle, Washington, part of University of Washington. Jay Rubinstein is also affiliated with Fred Hutchinson Cancer Center. The medical group on file is UW Physicians. Dmand AI also links Jay Rubinstein to 1 more hospital, 3 group practices and clinics, 2 medical groups and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Jay Rubinstein practices, 7 sites in all. Vendor and product names are available with a free account.

Pediatric otolaryngology is Jay Rubinstein's primary specialty in the NPI Registry, under taxonomy code 207YP0228X. Jay Rubinstein is licensed in Washington.

CMS data shows 377 Medicare services from Jay Rubinstein across 7 procedure codes in 2024, for 215 Medicare patients. Medicare paid $21,191 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 215 Medicare patients who saw Jay Rubinstein in 2024. The largest group is 65 to 74, with 107 patients. 60% of them have high cholesterol, and 51% have high blood pressure. 12% are also on Medicaid. Their average risk score is 1.13, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Jay Rubinstein's median patient age at 54, with 55% women.

In 2024, Jay Rubinstein wrote 56 Medicare Part D claims for 27 patients. 93% of them were for generic drugs. CMS names the drug for 26 of them, across 1 drug with 11 or more claims each, at $232 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Jay Rubinstein for performance year 2024, reported through an alternative payment model (APM). Jay Rubinstein accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Jay Rubinstein as offering telehealth.

Dmand AI links 64 papers to Jay Rubinstein, published from 2011 to 2023. 2013 was the busiest year, with 5. The most frequent topics are Cochlear Implants, Cochlear Implantation and Speech Perception. Jay Rubinstein has published most often in Otol Neurotol. Jay Rubinstein's most frequent co-authors are David Louis Horn, MD, Justin Golub, MD and Kavita Dedhia, MD.

Dmand AI links Jay Rubinstein to 1 clinical trial. Conditions studied include Hearing Loss, High-Frequency and Hearing Loss. Open Payments lists research payments to Jay Rubinstein that name 2 trials.

CMS Open Payments shows 31 general payments to Jay Rubinstein from 6 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 69% of the total. Advanced Bionics, LLC paid the most, $59,601. It also lists 29 research payments totaling $6,614 from 2024 to 2025, naming 2 clinical trials.

Jay Rubinstein graduated from University of Washington School of Medicine in 1988.